Post-transcriptional regulation of germline mRNAs in C. elegans
线虫种系 mRNA 的转录后调控
基本信息
- 批准号:10610874
- 负责人:
- 金额:$ 34.51万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:3&apos Untranslated RegionsAddressAffinityAllelesAmino AcidsAnimalsAtmosphereBindingBinding SitesBiochemicalBiologicalBiological AssayBiologyCRISPR/Cas technologyCaenorhabditis elegansCellsChildClustered Regularly Interspaced Short Palindromic RepeatsCommunitiesCoupledCritical PathwaysDataDatabasesDevelopmentDevelopmental ProcessDiseaseElementsEmbryoEmbryonic DevelopmentEngineeringEnsureEventFertilizationGenesGeneticGenetic ScreeningGenomeIn VitroIndividualInstructionInvertebratesLearningMammalsMapsMaternal Messenger RNAMediatingMeiosisMessenger RNAMolecularMutagenesisMutateMutationNatureNematodaOogenesisOutcomeParentsPatternPattern FormationPhenotypePhysiologicalPlayPositioning AttributePost-Transcriptional RegulationPropertyProteinsRNARNA BindingRNA interference screenRNA-Binding ProteinsRegulationRegulatory ElementReporterReporter GenesReproductionReproductive HealthResearchRoleSeriesSexual ReproductionSiteSpecificitySterilityTechnologyTestingTimeTranscriptTransgenesTransgenic OrganismsTranslatingUntranslated RegionsWorkcandidate identificationcell fate specificationexperimental studygene replacementgenome editingin vivoinnovationinterdisciplinary approachinterestmRNA Expressionmedical schoolsmutantoocyte maturationposttranscriptionalreproductivestoichiometrytemporal measurementtoolunpublished workszygote
项目摘要
Project Summary:
My lab is interested in defining how the maternal load is established during oogenesis and decoded
after fertilization. We know the identity of most important maternal transcripts and maternally supplied RNA-
binding proteins. We know that these factors are required for germline development, oocyte maturation, and
pattern formation in early embryogenesis. But we do not yet know which regulatory events are most important
for reproduction, or what mechanisms coordinate regulation in space and time.
We employed a “protein-centric” approach to map the wiring diagram of maternal RNA regulation in the
nematode Caenorhabidits elegans. We defined the sequence motifs recognized by a several maternal RNA-
binding proteins (RBPs) and identified of functional cis-regulatory elements in 3’UTR reporter genes
representing well studied maternal mRNAs. Our work made revealed that binding specificity is not sufficient to
explain mRNA targeting in vivo. All proteins studied to date bind to short linear partially degenerate motifs
present in at least 30-50% of all mRNAs. In some cases, the motifs have been shown to be necessary but not
sufficient to drive regulatory activity. In other cases, the motifs do not lead to regulation. Putting a motif, even in
multiple copies, into a transgene does not confer RBP-dependent regulation. Binding is not a great predictor of
regulation, revealing that binding site context is also crucial for targeting.
Moving forward, we are pursuing three major strategies. In the first, we are using CRISPR-cas9
genome editing to make mutations in the 3’UTRs of two critical maternal transcripts in order to identify which
regulatory events are most important to define the pattern of expression and for reproductive health. Genome
editing technology has advanced to the point where we can make targeted UTR deletions and substitutions, so
now we can assess importance directly. Our second direction is aimed at defining regulatory mechanisms. We
are performing AID-degron tagged experiments to define how RBPs and core regulatory machinery control the
maternal mRNA expression with temporal resolution in the germline and in the embryo. Finally, we wish to
understand how the biochemical properties of an RBP contribute to its mutant phenotypes. Proteins can have
multiple activities, and it is not always clear that the most obvious activity is the one that underlies its mutant
phenotypes. We are in position to address this question directly. We have expressed and purified several C.
elegans RBPs over the course of the past ten years and have begun to dissect their biochemical properties
using quantitative in vitro tools. We now have the ability to introduce mutations that effect RNA-binding
properties into the endogenous locus in C. elegans to determine phenotype.
Our innovative interdisciplinary approach, coupled to the strong atmosphere at UMass Medical School
in RNA biology and C. elegans genetics, will ensure rapid progress in defining the maternal effect in
embryogenesis at the functional level.
项目概要:
我的实验室有兴趣定义卵子发生过程中母体负荷是如何建立和解码的
受精后,我们知道最重要的母体转录物和母体提供的RNA-的身份。
我们知道这些因子是种系发育、卵母细胞成熟和发育所必需的。
但我们还不知道哪些调控事件是最重要的。
繁殖,或者什么机制协调空间和时间的调节。
我们采用“以蛋白质为中心”的方法来绘制母体 RNA 调节的接线图
我们定义了线虫 Caenorhabidits elegans 的几个母体 RNA 识别的序列基序。
结合蛋白 (RBP) 并鉴定 3'UTR 报告基因中的功能性顺式调控元件
我们的工作表明,结合特异性不足以代表母体 mRNA。
解释迄今为止研究的所有蛋白质都与短线性部分简并基序结合。
存在于至少 30-50% 的 mRNA 中。在某些情况下,这些基序已被证明是必要的,但并非如此。
在其他情况下,主题不会导致监管,即使是在其中。
转基因中的多个拷贝不会赋予 RBP 依赖性调节。
监管,揭示结合位点背景对于靶向也至关重要。
展望未来,我们正在推行三大战略:首先,我们正在使用 CRISPR-cas9。
基因组编辑使两个关键母体转录本的 3’UTR 发生突变,以确定哪些
调控事件对于定义表达模式和基因组健康最为重要。
编辑技术已经进步到我们可以进行有针对性的UTR删除和替换,所以
现在我们可以直接评估重要性。
正在进行 AID-degron 标记实验,以定义 RBP 和核心调节机制如何控制
最后,我们希望在种系和胚胎中具有时间分辨率的母体 mRNA 表达。
了解 RBP 的生化特性如何影响其突变蛋白的表型。
多种活性,并且并不总是清楚最明显的活性是其突变体的基础活性
我们已经表达并纯化了几个 C.
在过去的十年里,我们对线虫的 RBP 进行了研究,并开始剖析它们的生化特性
使用定量体外工具,我们现在有能力引入影响 RNA 结合的突变。
特性进入秀丽隐杆线虫的内源基因座以确定表型。
我们创新的跨学科方法,加上麻省大学医学院的浓厚氛围
RNA生物学和线虫遗传学方面的研究将确保在定义母体效应方面取得快速进展
功能水平上的胚胎发生。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sean Patrick Ryder其他文献
Sean Patrick Ryder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sean Patrick Ryder', 18)}}的其他基金
Post-transcriptional regulation of germline mRNAs in C. elegans
线虫种系 mRNA 的转录后调控
- 批准号:
10390502 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
Post-transcriptional regulation of germline mRNAs in C. elegans
线虫种系 mRNA 的转录后调控
- 批准号:
10390502 - 财政年份:2022
- 资助金额:
$ 34.51万 - 项目类别:
Repurposing systemic RNAi to simplify genome editing in nematodes
重新利用系统性 RNAi 简化线虫基因组编辑
- 批准号:
10077875 - 财政年份:2020
- 资助金额:
$ 34.51万 - 项目类别:
Repurposing systemic RNAi to simplify genome editing in nematodes
重新利用系统性 RNAi 简化线虫基因组编辑
- 批准号:
9916037 - 财政年份:2020
- 资助金额:
$ 34.51万 - 项目类别:
Comparative HTS to identify small molecule effectors of cell fate specification
比较 HTS 来识别细胞命运规范的小分子效应物
- 批准号:
8636032 - 财政年份:2012
- 资助金额:
$ 34.51万 - 项目类别:
Comparative HTS to identify small molecule effectors of cell fate specification
比较 HTS 来识别细胞命运规范的小分子效应物
- 批准号:
8293883 - 财政年份:2012
- 资助金额:
$ 34.51万 - 项目类别:
Comparative HTS to identify small molecule effectors of cell fate specification
比较 HTS 来识别细胞命运规范的小分子效应物
- 批准号:
8449117 - 财政年份:2012
- 资助金额:
$ 34.51万 - 项目类别:
RNA recognition by maternal gene silencers in nematodes
线虫母体基因沉默子对 RNA 的识别
- 批准号:
8010022 - 财政年份:2010
- 资助金额:
$ 34.51万 - 项目类别:
RNA recognition by maternal gene silencers in nematodes
线虫母体基因沉默子对 RNA 的识别
- 批准号:
7778223 - 财政年份:2008
- 资助金额:
$ 34.51万 - 项目类别:
RNA recognition by maternal gene silencers in nematodes
线虫母体基因沉默子对 RNA 的识别
- 批准号:
7596490 - 财政年份:2008
- 资助金额:
$ 34.51万 - 项目类别:
相似海外基金
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
- 批准号:
10822502 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
SELENOF 是一种新型肿瘤抑制剂,也是克服乳腺癌种族差异的新靶点。
- 批准号:
10735662 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
Restriction of KSHV by cellular RNA decay pathways
细胞 RNA 衰变途径对 KSHV 的限制
- 批准号:
10699800 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
HMGA2 mediates resistance to therapy in prostate cancer
HMGA2 介导前列腺癌治疗耐药
- 批准号:
10622747 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别:
The Role of mRNA Degradation in Embryonic Cell Fate Specification
mRNA 降解在胚胎细胞命运规范中的作用
- 批准号:
10604512 - 财政年份:2023
- 资助金额:
$ 34.51万 - 项目类别: